Company intelligence / Profile preview

Enhanced Nature

Ownership: Private
Development stage: Commercial

Overview

Enhanced Nature is a newly formed US company supplying arbuscular mycorrhizal fungi-based bionutrients aimed at improving crop yields and supporting sustainable agriculture. There are no clinical results as the company does not operate in the pharmaceutical or therapeutic space.

Therapeutic areas: Other
Modalities: Live biotherapeutic product therapy
Industry: Agriculture & AgTech

Drug pipeline

5 assets

ROW CROP

Commercial

Indications: Row crops

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Enhanced Nature.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enhanced Nature.

Explore the full profile